Timothy J. Hobday
- Neurology top 0.2%
- Neuroblastoma Research and Treatments 53
- Oncology top 0.5%
- Lung Cancer Research Studies 62
- Cancer Treatment and Pharmacology 23
- HER2/EGFR in Cancer Research 12
- Colorectal Cancer Treatments and Studies 11
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances 72
- Cancer Research top 5%
- Breast Cancer Treatment Studies 15
-
- Advanced Breast Cancer Therapies 11
- Co-authors
- James C. YaoEric Van CutsemKjell ÖbergManisha H. ShahEdward M. WolinDavid LebwohlT HaasSakina Hoosen
- Cited by
- NeurologyOncologyEpidemiology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (58 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Timothy J. Hobday
134 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Neurology 2.7k
- Oncology 4.7k
- Epidemiology 3.9k
- Cancer Research 632
- Pulmonary and Respiratory Medicine 678
Countries citing papers authored by Timothy J. Hobday
This map shows the geographic impact of Timothy J. Hobday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Hobday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Hobday more than expected).
Fields of papers citing papers by Timothy J. Hobday
This network shows the impact of papers produced by Timothy J. Hobday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Hobday. The network helps show where Timothy J. Hobday may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Timothy J. Hobday, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 17 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 26 | |
| 10 | 2019 | 11 | |
| 11 | 2018 | 72 | |
| 12 | QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors | 2018 | 3 |
| 13 | 2018 | 8 | |
| 14 | 2017 | 31 | |
| 15 | NETTER-1 Phase III Trial : Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine Tumors | 2017 | 2 |
| 16 | 2016 | 192 | |
| 17 | 2014 | 96 | |
| 18 | Analysis of Progression-Free Survival (PFS) by Prior Chemotherapy Use and Updated Safety in RADIANT-3: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial of Everolimus in Patients with Advanced Low- or Intermediate-Grade Pancreatic Neuroendocrine Tumors (pNET) | 2012 | 2 |
| 19 | 2011 | 45 | |
| 20 | Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trialbreakdown → | 2009 | 487 |
About Timothy J. Hobday
Timothy J. Hobday is a scholar working on Oncology, Neurology and Epidemiology, having authored 138 papers that have together received 6.3k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (72 papers), Lung Cancer Research Studies (62 papers), Neuroblastoma Research and Treatments (53 papers), Cancer Treatment and Pharmacology (23 papers), Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (12 papers), Advanced Breast Cancer Therapies (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). The work is most often cited by research in Neurology (2.7k citations), Oncology (4.7k citations) and Epidemiology (3.9k citations). Timothy J. Hobday has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include James C. Yao, Eric Van Cutsem, Kjell Öberg, Manisha H. Shah, Edward M. Wolin, David Lebwohl, T Haas, Sakina Hoosen, Jaume Capdevila and Elisabeth G.E. de Vries. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.